ETV4 and neoplasm: Moreover, flow cytometry analyses showed that ETV4 knockdown decreased the percentages of CD11b+Ly6G+ TANs, but not CD11b+F4/80+ TAMs in the footpad tumor (Figure 4C and Figure S6C, Supporting Information).